---

BMEA stock forecast

Our latest prediction for Biomea Fusion Inc's stock price was made on the June 6, 2023 when the stock price was at 38.24$.

In the short term (2weeks), BMEA's stock price should underperform the market by -3.71%. During that period the price should oscillate between -9.27% and +4.93%.

In the medium term (3months), BMEA's stock price should underperform the market by -17.18%. During that period the price should oscillate between -32.42% and +6.03%.

Get email alerts

Create a solid portfolio with BMEA

Add BMEA to your portfolio and optimize it!

---

About Biomea Fusion Inc

biomea fusion, llc was formed in 2017 by a small group of biotech executives. we are dedicated to developing innovative medicines for patients. it is our goal to design and clinically develop patient friendly therapies with higher efficacy than the current standard of care. the more precise a therapeutic agent is, the better the potential outcomes for individual patients’ needs. we are a precision oncology company developing novel small molecules that target aggressive forms of cancer. patients with these aggressive tumors typically exhibit high mortality rates and suffer from inadequate treatment options. with our current program, we are targeting specific changes to the dna of patients, which can be isolated as key drivers for tumor growth. we leverage our internal expertise and compliment it with computational drug design technology to build novel medicines for the future. we have significantly invested in the upfront development of our targeted therapies and are conducting bro

At the moment the company generates 1070M USD in revenues.

On its last earning announcement, the company reported a loss of None$ per share.

The book value per share is 6.97$

Biomea Fusion Inc website